Nipro Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2016 and Full Year Ending March 31, 2017
August 09, 2016
Share
Nipro Corporation reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of JPY 89,124 million against JPY 88,097 million a year ago. Operating income was JPY 9,257 million against JPY 5,476 million a year ago. Ordinary income was JPY 2,185 million against JPY 5,852 million a year ago. Net income was JPY 213 million against JPY 3,904 million a year ago. Diluted earnings per share were JPY 1.14. Income before income taxes was JPY 2,091 million against JPY 6,061 million a year ago. Income before minority interests was JPY 280 million against JPY 3,990 million a year ago.
The company provided consolidated earnings guidance for the six months ending September 30, 2016 and full year ending March 31, 2017. For the six months, the company expects net sales of JPY 181,300 million, operating income of JPY 13,400 million, ordinary income of JPY 12,300 million, net income of JPY 7,800 million, earnings per share of JPY 45.94.
For the full year, the company expects net sales of JPY 375,000 million, operating income of JPY 30,200 million, ordinary income of JPY 27,900 million, net income of JPY 18,000 million, earnings per share of JPY 106.01.
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Nipro Corporation Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2016 and Full Year Ending March 31, 2017